| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |